FormFactor Director Sells $484,146 in Stock
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
FormFactor Inc director Stuart L. Merkadeau sold 23,600 shares of FORMF stock on 22 May 2026. The transaction was valued at $484,146 and reported to the Securities and Exchange Commission. The sale reduced Merkadeau's direct holdings in the semiconductor test and measurement company. It occurred during a pivotal week for the firm ahead of its first-quarter earnings call.
The trade aligns with a standard practice for FormFactor executives to sell shares following quarterly vesting events. On 15 May 2024, a different FormFactor director executed a sale of $351,870 in company stock. Such sales are often part of pre-arranged 10b5-1 trading plans, which allow insiders to schedule trades in advance to avoid accusations of trading on material non-public information. Director sales at FormFactor are not unusual but warrant attention due to their timing.
This transaction arrives as FormFactor prepares to report its Q1 2027 earnings on 29 May 2026. The semiconductor capital equipment sector faces renewed pressure from shifting demand cycles. The Philadelphia Semiconductor Index (SOX) is down 4.2% year-to-date, underperforming the broader S&P 500's 8.1% gain. Investor focus is on order visibility and margins for companies like FormFactor.
The catalyst for market scrutiny is the proximity of the sale date to the earnings announcement. Regulatory filings show the transaction was executed on the open market. While likely part of a scheduled plan, the sale's magnitude and timing precede a key corporate event that can move the stock. The sale will be a focal point for analysts on the upcoming earnings call.
Merkadeau sold his shares at an average price of $20.52 per share. FormFactor's stock closed at $20.48 on the day of the transaction, 22 May 2026. The company's current market capitalization stands at approximately $1.58 billion based on that closing price. The director's sale represented roughly 0.015% of FormFactor's total outstanding shares.
The trade's value of $484,146 is significant when compared to average daily trading volume. FormFactor's 30-day average volume is 494,000 shares. This single sale represented nearly 5% of that average daily volume, indicating a material inflow of shares into the market. For context, a comparable director sale in May 2024 involved 15,000 shares valued at $351,870, implying a lower per-share sale price two years prior.
Performance data shows FormFactor stock is down 7.8% over the past month. The SOX index has declined 5.1% over the same period. This indicates the stock has underperformed its primary sector benchmark recently. The stock's 52-week range is $16.11 to $27.44, placing the sale price near the midpoint of that range.
The sale reinforces a cautious stance on near-term prospects for semiconductor equipment suppliers. Companies like Teradyne and Cohu, which compete with FormFactor in probe card and test system markets, may see indirect pressure as investors scrutinize insider sentiment across the sector. A sustained insider selling trend could signal broader concerns about capital expenditure cycles from major chipmakers like TSMC and Intel.
A key counter-argument is that this is a routine, planned transaction unrelated to the impending earnings report. Directors often sell to diversify personal portfolios or for liquidity needs unrelated to company performance. Historical data shows FormFactor stock has risen following similar insider sales in the past, negating a direct predictive link.
Positioning data indicates short interest in FormFactor has increased by 12% over the last month. Hedge funds and institutional investors are monitoring the equipment sector for signs of a downturn. Market flow is rotating toward semiconductor design software firms like Cadence Design Systems and Synopsys, which are seen as more insulated from cyclical hardware demand.
The primary immediate catalyst is FormFactor's Q1 2027 earnings release scheduled for 29 May 2026. Analysts will seek commentary on order book health and guidance for the second quarter. The subsequent conference call will likely feature questions regarding this director's sale and its context.
Key technical levels for FORMF stock include support at the 200-day moving average of $19.85 and resistance at the 50-day moving average of $21.30. A break below the $19.50 level could signal a test of the 52-week low. The SOX index level of 3,800 serves as a crucial sector sentiment gauge.
Further regulatory filings will reveal if other FormFactor insiders executed trades under similar 10b5-1 plans in the same window. The next major industry catalyst is the SEMI North American semiconductor equipment billings report due on 20 June 2026. That data will provide a macro check on equipment demand.
Not necessarily. Director and executive sales are frequently executed under pre-arranged 10b5-1 plans for portfolio diversification, tax planning, or personal financial needs. The transaction reported on 22 May 2026 was likely planned months in advance. Investors should be more concerned with clusters of unplanned sales by multiple insiders, which this single transaction does not represent.
Insider selling has been modest across the semiconductor equipment sector in recent months. Compared to a large $12 million CEO sale at a competitor in early 2026, the FormFactor director's $484,146 transaction is relatively small. Sector-wide, insider buying has been virtually absent, suggesting a neutral-to-cautious outlook is prevalent, not uniquely bearish for FormFactor. For more on sector trends, see our analysis of the chip cycle on Fazen Markets.
FormFactor stock has shown no consistent pattern following insider sales over the past five years. After a $351,870 director sale in May 2024, the stock gained 8% over the following quarter. Conversely, a sale cluster in late 2022 preceded a 15% decline. The data indicates that other fundamental factors, like earnings results and industry demand, are stronger drivers of share price than isolated insider transactions.
The director's sale is a routine liquidity event overshadowed by the critical test of FormFactor's upcoming quarterly earnings.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.